High-Dose Busulfan and Thiotepa Followed by Autologous Stem Cell Transplantation for Refractory Choriocarcinoma with Central Nervous System Metastases: A Case Report
Case Reports in Oncology · 2026-09-08 · 19 (1) · 1378-1385
DOI: 10.1159/cro/abzag042 ↗Abstract
Introduction: Choriocarcinoma is particularly challenging to treat when it has metastasized to the central nervous system. Although metastatic choriocarcinoma generally responds well to therapy, brain metastases are associated with markedly poorer survival and can lead to severe neurological complications. One of the main challenges is that standard chemotherapy regimens, such as high-dose platinum derivatives and etoposide, do not effectively cross the blood-brain barrier, preventing adequate control in the central nervous system. For many, often relatively young patients, treatment options become severely limited when radiotherapy is contraindicated or has already been administered and surgery is not feasible. Case Presentation: In this study, we describe the successful repurposing of a high-dose chemotherapy regimen consisting of busulfan and thiotepa in a patient with brain metastatic choriocarcinoma unresponsive to carboplatin and etoposide. These agents, widely used in central nervous system lymphoma, are well known for their ability to penetrate the blood-brain barrier. Treatment with this regimen resulted in stable disease and, most importantly, restored a very good quality of life for the patient. Conclusion: This case suggests a practical and novel therapeutic approach for managing choriocarcinoma with brain metastases, particularly in patients who have already received radiotherapy and are not candidates for further irradiation or surgery.
EUVIMED